Hyaluronan up-regulates IL-10 expression in fibroblast-like synoviocytes from patients with tibia plateau fracture

Teng Le Huang, Horng Chaung Hsu, Kai Chiang Yang, Feng Huei Lin

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Progression to osteoarthritis (OA) is a frequent sequela of severe articular fracture, particularly when weight-bearing joints are involved. Prevention from post-traumatic OA remains a challenge. Hyaluronan (HA) therapy is reported to represent a safe and effective treatment for patients with OA and rheumatoid arthritis. However, the capacity of HA to prevent the occurrence of osteoarthritic changes in fractured joints has not been demonstrated. The present study was undertaken to examine the effects of HA on expression of six OA-related proteins in fibroblast-like synoviocytes (FLS) from 10 patients with tibia plateau fracture. OA-related factors were quantified using a sandwich enzyme-linked immunosorbent assay. Regardless of induction of the FLS with interleukin (IL)-1β, HA was found to down-regulate expression of catabolic factors (IL-1β, matrix metalloproteinase-3, and tumor necrosis factor-a) and to up-regulate production of anticatabolic factors (tissue inhibitors of metalloproteinase-1 and metalloproteinase-2). HA also enhanced expression of IL-10, an antiinflammatory cytokine, in FLS. Our results indicated that HA can promote the expression of both antiinflammatory and structure-protective factors in FLS of patients with tibia plateau fracture.

Original languageEnglish
Pages (from-to)495-500
Number of pages6
JournalJournal of Orthopaedic Research
Volume29
Issue number4
DOIs
Publication statusPublished - Apr 2011
Externally publishedYes

Fingerprint

Hyaluronic Acid
Tibia
Interleukin-10
Up-Regulation
Osteoarthritis
Fibroblasts
Joints
Interleukin-1
Anti-Inflammatory Agents
Matrix Metalloproteinase 3
Tissue Inhibitor of Metalloproteinase-1
Weight-Bearing
Metalloproteases
Synoviocytes
Rheumatoid Arthritis
Down-Regulation
Tumor Necrosis Factor-alpha
Enzyme-Linked Immunosorbent Assay
Cytokines
Therapeutics

Keywords

  • Hyaluronan
  • Synoviocyte
  • Tibia plateau fracture

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Hyaluronan up-regulates IL-10 expression in fibroblast-like synoviocytes from patients with tibia plateau fracture. / Huang, Teng Le; Hsu, Horng Chaung; Yang, Kai Chiang; Lin, Feng Huei.

In: Journal of Orthopaedic Research, Vol. 29, No. 4, 04.2011, p. 495-500.

Research output: Contribution to journalArticle

@article{ead1f9b90e124d20b0709e73746a9c7a,
title = "Hyaluronan up-regulates IL-10 expression in fibroblast-like synoviocytes from patients with tibia plateau fracture",
abstract = "Progression to osteoarthritis (OA) is a frequent sequela of severe articular fracture, particularly when weight-bearing joints are involved. Prevention from post-traumatic OA remains a challenge. Hyaluronan (HA) therapy is reported to represent a safe and effective treatment for patients with OA and rheumatoid arthritis. However, the capacity of HA to prevent the occurrence of osteoarthritic changes in fractured joints has not been demonstrated. The present study was undertaken to examine the effects of HA on expression of six OA-related proteins in fibroblast-like synoviocytes (FLS) from 10 patients with tibia plateau fracture. OA-related factors were quantified using a sandwich enzyme-linked immunosorbent assay. Regardless of induction of the FLS with interleukin (IL)-1β, HA was found to down-regulate expression of catabolic factors (IL-1β, matrix metalloproteinase-3, and tumor necrosis factor-a) and to up-regulate production of anticatabolic factors (tissue inhibitors of metalloproteinase-1 and metalloproteinase-2). HA also enhanced expression of IL-10, an antiinflammatory cytokine, in FLS. Our results indicated that HA can promote the expression of both antiinflammatory and structure-protective factors in FLS of patients with tibia plateau fracture.",
keywords = "Hyaluronan, Synoviocyte, Tibia plateau fracture",
author = "Huang, {Teng Le} and Hsu, {Horng Chaung} and Yang, {Kai Chiang} and Lin, {Feng Huei}",
year = "2011",
month = "4",
doi = "10.1002/jor.21261",
language = "English",
volume = "29",
pages = "495--500",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Hyaluronan up-regulates IL-10 expression in fibroblast-like synoviocytes from patients with tibia plateau fracture

AU - Huang, Teng Le

AU - Hsu, Horng Chaung

AU - Yang, Kai Chiang

AU - Lin, Feng Huei

PY - 2011/4

Y1 - 2011/4

N2 - Progression to osteoarthritis (OA) is a frequent sequela of severe articular fracture, particularly when weight-bearing joints are involved. Prevention from post-traumatic OA remains a challenge. Hyaluronan (HA) therapy is reported to represent a safe and effective treatment for patients with OA and rheumatoid arthritis. However, the capacity of HA to prevent the occurrence of osteoarthritic changes in fractured joints has not been demonstrated. The present study was undertaken to examine the effects of HA on expression of six OA-related proteins in fibroblast-like synoviocytes (FLS) from 10 patients with tibia plateau fracture. OA-related factors were quantified using a sandwich enzyme-linked immunosorbent assay. Regardless of induction of the FLS with interleukin (IL)-1β, HA was found to down-regulate expression of catabolic factors (IL-1β, matrix metalloproteinase-3, and tumor necrosis factor-a) and to up-regulate production of anticatabolic factors (tissue inhibitors of metalloproteinase-1 and metalloproteinase-2). HA also enhanced expression of IL-10, an antiinflammatory cytokine, in FLS. Our results indicated that HA can promote the expression of both antiinflammatory and structure-protective factors in FLS of patients with tibia plateau fracture.

AB - Progression to osteoarthritis (OA) is a frequent sequela of severe articular fracture, particularly when weight-bearing joints are involved. Prevention from post-traumatic OA remains a challenge. Hyaluronan (HA) therapy is reported to represent a safe and effective treatment for patients with OA and rheumatoid arthritis. However, the capacity of HA to prevent the occurrence of osteoarthritic changes in fractured joints has not been demonstrated. The present study was undertaken to examine the effects of HA on expression of six OA-related proteins in fibroblast-like synoviocytes (FLS) from 10 patients with tibia plateau fracture. OA-related factors were quantified using a sandwich enzyme-linked immunosorbent assay. Regardless of induction of the FLS with interleukin (IL)-1β, HA was found to down-regulate expression of catabolic factors (IL-1β, matrix metalloproteinase-3, and tumor necrosis factor-a) and to up-regulate production of anticatabolic factors (tissue inhibitors of metalloproteinase-1 and metalloproteinase-2). HA also enhanced expression of IL-10, an antiinflammatory cytokine, in FLS. Our results indicated that HA can promote the expression of both antiinflammatory and structure-protective factors in FLS of patients with tibia plateau fracture.

KW - Hyaluronan

KW - Synoviocyte

KW - Tibia plateau fracture

UR - http://www.scopus.com/inward/record.url?scp=79951874707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951874707&partnerID=8YFLogxK

U2 - 10.1002/jor.21261

DO - 10.1002/jor.21261

M3 - Article

VL - 29

SP - 495

EP - 500

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 4

ER -